LRMR Stock Analysis: Buy, Sell, or Hold?
LRMR - Larimar Therapeutics, Inc. Common Stock
$3.58
-0.31 (-7.97%)
▼
5d:
-9.82%
30d:
-24.15%
90d:
+13.65%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Accumulation
LRMR is down 9.8% this week, but smart money is accumulating calls. Top strike: $5 2026-06-18 with 296 OI. Call ratio: 100% View Scanner →
Strength: 9.9/10
Get Alerted When LRMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called LRMR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LRMR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LRMR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LRMR is currently trading at $3.58, which is considered oversold relative to its 30-day fair value range of $4.04 to $4.86.
Technical Outlook: Technically, LRMR is in a strong uptrend. Immediate support is located at $3.44, while resistance sits at $4.29. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: LRMR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.00 (+346.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LRMR is in a strong uptrend. Immediate support is located at $3.44, while resistance sits at $4.29. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: LRMR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.00 (+346.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.04 -
$4.86
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.0%)
- BULLISH: Trading 346.9% below Wall St target ($16.00)
- CAUTION: 5-day price weakness (-9.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.04 -
$4.86
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.44
Resistance Level
$4.29
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.17
Wall Street Target
$16.00
(+346.9%)
Share & Embed Analysis
Last updated: May 18, 2026 8:19 AM ET
Data refreshes hourly during market hours. Next update: 9:19 AM
Data refreshes hourly during market hours. Next update: 9:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LRMR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
James E Flynn
BUY
5000000 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 60 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$181 | 61 BUY |
